AMGEN INC PP&E Net 2008-2026 | AMGN
Beta
What is AMGEN INC's current pp&e net?
AMGEN INC (AMGN) annual pp&e net for 2025 was $7.91B, a 20.94% increase from 2024. AMGEN INC pp&e net for the quarter ending March 31, 2026 was $8.22B.
What was AMGEN INC's pp&e net in 2024?
AMGEN INC annual pp&e net for 2024 was $6.54B, a 10.13% increase from 2023.
What was AMGEN INC's pp&e net in 2023?
AMGEN INC annual pp&e net for 2023 was $5.94B, a 9.47% increase from 2022.
What is AMGEN INC's 5-year pp&e net CAGR?
AMGEN INC pp&e net grew at a compound annual growth rate (CAGR) of 10.11% from FY2020 to FY2025, going from $4.89B to $7.91B over 5 years.
PP&E Net History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+10.1%
FY2020
$4.89B
→
FY2025
$7.91B
080910111213141516171819202122232425
5 years selected
PP&E Net History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $7.91B | +20.9% | 10-K |
| FY2024 | $6.54B | +10.1% | 10-K |
| FY2023 | $5.94B | +9.5% | 10-K |
| FY2022 | $5.43B | +4.7% | 10-K |
| FY2021 | $5.18B | +6.0% | 10-K |
| FY2020 | $4.89B | -0.8% | 10-K |
| FY2019 | $4.93B | -0.6% | 10-K |
| FY2018 | $4.96B | -0.6% | 10-K |
| FY2017 | $4.99B | +0.6% | 10-K |
| FY2016 | $4.96B | +1.1% | 10-K |
| FY2015 | $4.91B | -6.1% | 10-K |
| FY2014 | $5.22B | -2.4% | 10-K |
| FY2013 | $5.35B | +0.4% | 10-K |
| FY2012 | $5.33B | -1.7% | 10-K |
| FY2011 | $5.42B | -1.8% | 10-K |
| FY2010 | $5.52B | -3.8% | 10-K |
| FY2009 | $5.74B | -2.4% | 10-K |
| FY2008 | $5.88B | - | 10-K |
Company: AMGEN INCTicker: AMGNSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →